161 search results for “e cell” in the Staff website
-
Daisy Batenburgd.batenburg@lacdr.leidenuniv.nl | 071 5272727
-
Kim Elbertsek.elbertse@lacdr.leidenuniv.nl | 071 5272727
-
Elsa Neuberte.neubert@lacdr.leidenuniv.nl | 071 5272727
-
Andraniek Evadgian -
Valedictory lecture prof.dr. E. van Dijk
Valedictory lecture
-
High-throughput screening using fluorescent cell models for mechanistic evaluation of adverse drug reactions
PhD defence
-
Assessment matrices
When putting together your assessment, it may be useful to use an assessment matrix. This is a table in which you link the learning objectives to test questions and indicate the weight you give each objective in the assessment. It can be requested in the context of a programme accreditation.
-
Annaloes Fokkelman-Klipj.e.fokkelman@lacdr.leidenuniv.nl | 071 5274496
-
Kirsten Veltmanc.h.j.veltman@lacdr.leidenuniv.nl | 071 5272727
-
Xiaobing Zhangx.zhang@lacdr.leidenuniv.nl | 071 5272727
-
Lukas Wijayal.s.wijaya@lacdr.leidenuniv.nl | 071 5275706
-
Sabine de Winters.de.winter@lacdr.leidenuniv.nl | 071 5272727
-
Linglu Xul.xu@lacdr.leidenuniv.nl | 071 5276039
-
Britt Duijndamb.h.a.duijndam@lacdr.leidenuniv.nl | 071 5272727
-
Filippo di Tilliof.di.tillio@lacdr.leidenuniv.nl | 071 5272727
-
Lucy Sinkel.j.sinke@lacdr.leidenuniv.nl | 071 5276039
-
Mick van Schaickm.van.schaick@lacdr.leidenuniv.nl | 071 5272727
-
Gerard Mulderg.mulder@lacdr.leidenuniv.nl |
-
Arnoud Sonnenberga.sonnenberg@nki.nl | 071 5272727
-
Zoran Gavricz.gavric@lacdr.leidenuniv.nl |
-
Natasha Tahirn.tahir@lacdr.leidenuniv.nl | 071 5275919
-
Michiel van Dijkm.van.dijk@lacdr.leidenuniv.nl | 071 5274496
-
Tamara Danilyukt.y.danilyuk@lacdr.leidenuniv.nl | 071 5275919
-
Klara Beslmüllerk.beslmuller@lacdr.leidenuniv.nl | 071 5272727
-
Elpida Lymperie.lymperi@lacdr.leidenuniv.nl | 071 5276039
-
Jaco van Veldhovenj.van.veldhoven@science.leidenuniv.nl | 071 5274333
-
Vera van der Noordv.e.van.der.noord@lacdr.leidenuniv.nl | 071 5276225
-
Johannes Schimmingj.p.schimming@lacdr.leidenuniv.nl | 071 5272727
-
Ine Tijdenstijdens@lacdr.leidenuniv.nl |
-
Chantal Pontc.pont@lacdr.leidenuniv.nl | 071 5276302
-
Jurjun van der Veldej.j.s.van.der.velde@lacdr.leidenuniv.nl | 071 5272727
-
Bart Lenselinke.b.lenselink@lacdr.leidenuniv.nl | 071 5272727
-
Yuanyuan Maoy.mao@cml.leidenuniv.nl | 071 5272727
-
Paul Hooykaasp.j.j.hooykaas@biology.leidenuniv.nl | 071 5274933
-
Marije Niemeijerm.c.niemeijer@lacdr.leidenuniv.nl | 071 5276105
-
Chenlin Fengc.l.feng@lacdr.leidenuniv.nl | 071 5272727
-
Tessa Hagenst.m.s.hagens@lacdr.leidenuniv.nl | 071 5275706
-
Jos Jonkersj.m.m.jonkers@lacdr.leidenuniv.nl | 071 5272727
-
Maarten Lubbersm.lubbers@biology.leidenuniv.nl | 071 5275075
-
Hendrikus Tankeh.j.tanke@lumc.nl | 071 5269201
-
LUMC participates in pioneering type 1 diabetes research
The promising early results of an international study have shown that insulin-producing cells grown from stem cells can cure the disease. The new Cure One LUMC research centre aims to accelerate this breakthrough.
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
Veni grant for ten Leiden researchers
Ten Leiden researchers have been awarded a Veni grant by the Dutch Research Council (NWO). The grant, of up to 280,000 euros, will enable them to elaborate their ideas over a period of three years.
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Susana ValdezFaculty of Humanities
s.valdez@hum.leidenuniv.nl | 071 5278984
-
New traffic controller discovered on DNA railway
A new LUMC study has changed our understanding of how cells work. Researchers have discovered that the CFAP20 protein acts as a kind of ‘traffic controller’ on DNA. Without this protein, chaos ensues, potentially causing cancer. Their findings have been published in the prestigious journal Nature.
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.